Characterization of cells expressing lipocalin-2 (LCN2) as a reporter
Biochemistry and Cell Biology · 2024
DOI: 10.1139/bcb-2024-0013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2024. Verfasst von Kimihiko Sugaya. Beteiligte Einrichtung: Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST)…. Hauptthemen laut MEDLINE: Lipocalin-2. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Lipocalin-2 (LCN2), an effector molecule of the innate immune system that is small enough to be tagged as a reporter molecule, can be coupled with the ferric ion through a siderophore such as enterobactin (Ent). Mintbody (modification-specific intracellular antibody) can track a posttranslational protein modification in epigenetics. We constructed plasmids expressing the LCN2 hybrid of mintbody to examine the potential of LCN2 as a novel reporter for magnetic resonance imaging (MRI). Cells expressing the LCN2 hybrid of mintbody showed proper expression and localization of the hybrid and responded reasonably to Ent, suggesting their potential for in vivo study by MRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Imaging and Theranostics, Institute for Quantum Medical Science, National Institutes for Quantum Science and Technology (QST), Chiba, Japan.
ORCID-Profile: Kimihiko Sugaya
Zitieren
APA
Sugaya, K. (2024). Characterization of cells expressing lipocalin-2 (LCN2) as a reporter. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2024-0013
Vancouver
Sugaya K. Characterization of cells expressing lipocalin-2 (LCN2) as a reporter. Biochemistry and Cell Biology. 2024. doi:10.1139/bcb-2024-0013
BibTeX
@article{Sugaya2024,
author = {Sugaya, Kimihiko},
title = {Characterization of cells expressing lipocalin-2 (LCN2) as a reporter},
journal = {Biochemistry and Cell Biology},
year = {2024},
doi = {10.1139/bcb-2024-0013}
}
EUVIMED